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Abstract
Patients with severe cystic fibrosis who face lung transplant proposal react in different ways to the offer of this potentially life
prolonging therapy. Little is known about those patients who refused the operation. This article describes various behaviour
patterns and reactions following the transplant proposal. The major reasons for refusal of lung transplantation are based on
personal experiences and encounters and on psychological and medical considerations. Only a subgroup of patients sticks to the
initial decision of refusing the operation. Other patients question their decision and fluctuate between refusal and acceptance. A
third group of patients reverses the decision mostly as a result of a significant life event. The decision not to undergo lung
transplantation needs to be viewed as a reversible one and in the context of extreme physical and psychological vulnerability on
the part of the patients. Health professionals should recognise the potential for change, remain non-judgemental and flexible, and
adjust their services to the respective circumstances.
 2003 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
This paper focuses on persons with cystic fibrosis
(CF) who do not wish to undergo lung transplantation
(LTx) but who do not want to die. This seems to be an
unsolvable problem because physicians only suggest
transplantation when they fear a patient may die within
the foreseeable future. One may argue that there are
persons with CF who would accept the possibility of a
dignified death. Perhaps this is correct in a few cases.
More often such persons are primarily tired of suffering.
If one would offer them a life without suffering most,
if not all, would accept.
The topic of refusing lung transplantation thus far has
not drawn significant research attention. In fact, a
literature search proved unsuccessful in identifying any
appropriate papers. Studies that addressed referral and
evaluation of transplant candidates only refer to the
number of patients not accepted or refusing the operation
w1–5x. No study so far pursued patients with CF who
voluntarily refused LTx. In addition, a methodological
problem aggravates a systematic study of patients who
were offered LTx. Those who were considered candi-
dates in childhood or adolescence were later transferred
to adolescent or adult care and therefore lost to follow-
up. Given the lack of empirical studies this paper is
based on a 15 year clinical experience with heart-lung
and lung transplantation in children, adolescents, and
adults with CF. The aim is to describe the various
patterns of how patients proceed after they have refused
LTx.
2. Reasons for refusing lung transplantation
So why do people with severe CF who face progres-
sive health deterioration and significant impairment of
quality of life refuse a life prolonging therapy? I have
attributed the reasons for refusal to three categories,
although the boundaries should not be viewed as clear-
cut.
2.1. Reasons that are based on experiences and
encounters
This category refers to individual experiences and the
influence of significant others including fellow-patients,
friends, family members and staff members. A particu-
larly dreadful experience is the death of a fellow patient,
which may bring with it discouragement and the antic-
ipation of an unfavourable outcome for oneself. The
opinions, attitudes and beliefs of significant others are
strong and determining factors. If based on comprehen-
sive reflection they may well support the patient in
decision-making. If based primarily on subjective argu-
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Fig. 1. Reactions to transplant proposal.
ments with an emphasis on only the risks they are
counterproductive. In light of their mental and physical
weakness transplant candidates are susceptible to any
advice and often unable to recognise undue pressure
such as the clear recommendation ‘don’t do it’.
2.2. Psychological and psychosocial reasons
Some patients are afraid of the necessity to rely on
and become dependent on even more health profession-
als (HP), which is associated with feelings of being
abandoned by their familiar care providers. Some
patients simply believe that they will make it without
transplantation or that they even will live longer without
it. A number of patients seem to be able to accept a
given life-span on the grounds of a religious belief.
Most patients express fears and anxieties of any kind,
including the unknown outcome.
2.3. Medical reasons
Sometimes there is a discrepancy between the physi-
cian’s and the patient’s judgement. The patients may
find their health state acceptable or less severe than the
doctors or superior to patients who are not considered
for LTx. A very common reason refers to the fear of
acquiring a new disease which is based on the knowl-
edge that transplantation involves trading part of one
disease for an entire second disease. In addition to
possibly painful procedures the anticipation of many
complications and the perspective of life-long treatment
may be discouraging. The knowledge that nerves will
be severed and that this may result in a lack of control
over one’s health is another stressful aspect.
3. Behaviour patterns and decision-making following
refusal
Irrespective of which reason contributed most to the
decision to refuse LTx there are major patterns of
reacting and proceeding. In general a process that is
characterised by innumerable discussions of pros and
cons precedes and follows the initial refusal of LTx. It
is obvious that decision-making on a life improving, life
saving or life threatening operation often exceeds the
coping abilities and resources of those concerned. There-
fore and together with increasing confrontation with LTx
over time a refusal that may have thought to be irre-
versible in the beginning can take unexpected turns.
Whether or not a patient who withdraws hisyher refusal
undergoes LTx is predominantly dependent upon health
state, organ availabilty, and with respect to the different
health care systems, access to coverage of the (Fig. 1).
3.1. Sustained refusal: the ‘no–no’ group
Patients in this group stick to their decision, the initial
refusal remains, but they pursue two very different
strategies (Fig. 1). A subgroup of patients significantly
changes their lifestyle in as much as they mobilise all
their willpower and improve nutrition, to increase phys-
iotherapy and to set up an exercise program. They now
follow medication precisely and they often reduce their
workload. These patients view the proposal of LTX as
a temporary setback and are determined not to lose a
hard-fought battle. In the other subgroup no major
changes in lifestyle are made. Rather, these patients try
to pursue their normal life often coupled with the desire
to even undertake enterprises that seem to be far beyond
their present physical capabilities. In contrast to the
patients who increase adherence these patients want to
savour every moment, they want to enjoy life to the
brim, to live as best they can, and they vow to fight to
their last breath.
3.2. Doubts and untertainty: the ‘no–perhaps’ group
These patients’ initial ‘no’ turns, after a while and at
times into a ‘perhaps’. Typical comments circulate
around time and particular events (e.g. ‘Not now, maybe
later’; ‘After my holidays’; ‘After Christmas’; ‘Not
before my 30th birthday’). These patients change their
mind often, they make decisions and withdraw them
again. They refuse LTx when their health improves and
they are near to acceptance in case of deterioration.
They may be on the waiting list and withdraw them-
selves or even reject an available organ. They are
plagued by doubts and uncertainty and at times they do
not want to hear anything at all about LTx. These
patients are at high risk of waiting too long and coming
in too late. Whether or not their life is eventually
prolonged through LTx is predominantly a matter of
luck and immediate organ availability.
3.3. Changing mind: the ‘no–yes’ group
Individuals in this group may stick to the initial
refusal for a while and show hardly any doubts regarding
their decision. Then, all of a sudden, something signifi-
cant happens inducing these patients to reverse their
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Fig. 2. Fluctuations around decision-making.
decision. This can be a dramatic deterioration that brings
them so close to death that they now know that they
really do not want to die. It may be due to a tremendous
loss of quality of life that prevents them from pursuing
daily activities. Sometimes a religious belief has lost is
relevance and the potential prolongation of life does not
conflict with the respective faith anymore. But also
pleasant events like falling in love or finding an exciting
job may shed a promising new perspective on life and
encourage a patient to make any effort to go on living.
Mainly the two latter groups, and only to a smaller
extent the first group, exhibit a behaviour that may
greatly challenge the health professionals. It is the
enormous fluctuation around the decision toward LTx
(Fig. 2). Often the slightest improvements in health
status support and nurture refusal (a). There are patients
with advanced CF who are able to live and even to
work despite an FEV1% pred that circulates around 15.
Such severely ill patients may feel that they benefited
from therapy during the hospital admission though their
lung function hardly improved. But the subjective
impression of improvement may be more influential in
the belief that survival without LTx is possible than the
objective medical parameters. The fluctuation regarding
decision-making can be so pronounced that health pro-
fessionals may have difficulty tracking the patient’s
views. Even within hours a patient may switch from yes
to no and vice versa (b) and a decision on Friday
afternoon to undergo assessment may have turned into
refusal by Saturday morning (c).
4. How can health professionals support patients who
refuse LTx?
Given that many CF health professionals have known
their patients for years and contributed constantly to
prevent deterioration or to prolong life, a refusal of the
last therapy possible may represent a severe blow to a
dedicated team. Yet the patients who refuse LTx need
at least as much attention and support as before. It is
those who are under extraordinary stress, who are
threatened with death, and who are extremely vulnerable,
both medically and psychologically. It is normal and
understandable that terminally ill patients are frightened,
sad, desperate and confused. Therefore, health care
providers need to respect a patient’s refusal and to
convey their understanding and acceptance. Instead of
automatically providing a predetermined set of interven-
tions the patients should be asked what kind of support
they think they might need. There is no need to withhold
potentially helpful interventions including psychothera-
py, but the offers should be tailored to the patients’
needs and acceptance, or non-acceptance must be
respected. Information is a crucial issue. Health profes-
sionals should be willing and available to inform about
any item, in particular those that deal with the fear of
suffocating. The patients must know that they do not
have to suffer in the terminal phase since they may be
treated with opiates for terminal pain and dyspnea. The
patients must be reassured that they are free to change
their mind at any point in time and they should be
encouraged to initiate repeated discussions.
5. Conclusions
The necessity to confront LTx results in a process
that is associated with changing attitudes and temporary
decisions. Patients who refuse LTx may stick to this
decision or change their mind. In the beginning neither
the patients nor the health professionals know what
direction the initial decision will take. Therefore, it is
very important that the CF team remains non-judgemen-
tal and flexible, recognises the potential for change,
respects contradictory decisions, and adjusts its service
to the respective circumstances.
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